Clinical Experience of Patients Referred to a Multidisciplinary Cardiac Oncology Clinic: An Observational Study

Table 5

Cardiac outcomes ().

	(%)
Mode of prechemotherapy LVEF assessment	= 381
(i) ECHO	286 (5.1%)
(ii) MUGA	84 (22.0%)
(iii) Other/combined modalities	11 (2.9%)
(iv) Pre-chemo-LVEF (median)	60% (r: 25.0–81.2)
Change in LVEF	= 381
(i) No significant decline	232 (60.9%)
(ii) Any decline	196 (51.4%)
LVEF outcome	N = 196
(i) Full recovery	55 (28.0%)
(ii) Partial recovery	16 (8.2%)
(iii) Stable	59 (30.0%)
(iv) Progressive decline	55 (28.0%)
(v) Unknown	11 (5.8%)
Cardiac medication(s)	= 175
(i) ACE inhibitors	39 (22.3%)
(ii) Beta-blockers	22 (12.6%)
(iii) ACE inhibitors + beta-blockers	24 (13.7%)
(iv) Multiple	90 (51.4%)